Aristeia Capital’s Crown PropTech Acquisitions Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 CPTK.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-384,137
Closed -$220K 943
2021
Q4
$220K Buy
384,137
+357,437
+1,339% +$251K ﹤0.01% 521
2021
Q3
$14K Buy
+26,700
New +$18.9K ﹤0.01% 537

Other funds holding CPTK.WS

Aristeia Capital's CPTK.WS Position: Q1 2022 in Review

Aristeia Capital sold out of Crown PropTech Acquisitions Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (CPTK.WS) in Q1 2022, closing a stake of 384,137 shares — an estimated $220K sold.

Aristeia Capital first reported a position in CPTK.WS in Q3 2021 and held it in 2 quarters. The position peaked at $220K in Q4 2021. 53 funds tracked by Wall St. Rank hold CPTK.WS as of Q1 2022.

  • Aristeia Capital reported no remaining Crown PropTech Acquisitions Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
  • Aristeia Capital sold 384,137 Crown PropTech Acquisitions Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2022, an estimated $220K.
  • Aristeia Capital first reported a position in Crown PropTech Acquisitions Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2021 and held it in 2 quarters.
  • Aristeia Capital's Crown PropTech Acquisitions Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $220K in Q4 2021.
  • 53 funds tracked by Wall St. Rank held Crown PropTech Acquisitions Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2022.

Based on Aristeia Capital's 13F filing for Q1 2022, filed 16 May 2022.